Member Info for Mikemine

There are over 800,000 active physicians directly dealing with patients in the USA. Presumably any of them can order any FDA approved test they deem fit. A good proportion of those will leave the testing to nephrologists but many doctors might be tempted to test their low grade diabetic patients now it's easier and with more certain results. Some diabetic patients may well decide it's worth the expense of having the test especially if it is paid for by their insurance. I know I would even if I had to pay out of my own pocket. We can only guess at the potential but by any standards it must be huge.

I have no real understanding of MM methods but I see a smallish amount of selling having a disproportionate effect on the SP to a large amount of buying. call it what you will.

T. You seem to be pretty familiar with Tempus so is the 22.000 figure all the physicians they have reached so far or is that the sum total of physicians in the renal area in the USA? If the reached number is growing that is even better.

The MMs are certainly taking every opportunity they can to push the SP lower.

Where did the figure 22,000 physicians come from? McCullough was talking about 250,000 from memory.

That's a great post hasg. Not just from investors point of view but all of us need to know how things are developing in medicine. I guess things are happening along the same lines with all the organs of the body.

Getting back to RENX and Tempus, you can see there is very bright future ahead. They are a perfect match and Tempus one will go down extremely well with physicians.

I have the same feeling as yesterday that the SP is being held down for whatever reason. Buys outnumber sells by about 2:1 yet the SP is down. Not normal market behaviour

What is wrong with computers today? It should read "Looks like people just can't stop buying." but the computer thought it knew best.

Looks like people just can't buying. Can't blame them.

Had a quick look on Tempus's website and looked at Tempus One, their latest offering for physicians. You can see how slick it is with box ticking at its core. It must be a dream to use. No wonder Tempus is storming and you can see how KidneyIntelX would fit right in there. Linking up with RENX would be a no brainer for Tempus.

https://www.tempus.com/about-us/tempus-tech/one/

I've often wondered what NT stands for.

It doesn't work with Safari

Just had a top up but had to pay 10.15P. Anywhere around that price would have done though. In to the bottom drawer they go.

It's worth looking at the Tempus website. Their commercial offerings are far different to what has happened before. They make full use of AI and digital technology. You can quite see how KidneyIntelX fits right in there. No wonder Tempus is rated so highly and now RENX is in the mix.

https://www.tempus.com/?srsltid=AfmBOoqj_wqdTm5zex-wCOyXi7sklg_EwaOBEjCXrHPdDsS9_TQhCcMu

Sorry, should have been 11 million shares.

Can't recollect any similar course of events in other fund raising elsewhere. Obviously institutions are happy to get in at 9.5P and presumably wait for the deal to kick in with added revenue. The latest RNS is strange in that they subscribed at above the Market rate but I suppose they thought that trying to buy 5 million shares in the open Market would take the SP over 9.5P anyway so why bother and the money would be lost to RENX as well. Maybe that how the CEO sold it. Whatever way, RENX has another £1mn. Makes you wonder if we'll see a more stakes taken.

That's a great insight Thirty5KR. Many thanks for that. Patience needed as ever.

Thats a welcome insight Ramptastico but, if the test only rolled out to Tempus's existing coverage, the revenue would increase substantially. Maybe thats in the forecasts but it seems a big underestimation if it is IMHO. If Tempus grows like you indicate, the figures will be larger of course.

Maybe this is why the BOD are taking time to consider what the link up might realistically mean. No doubt we'l have another update in the near future.

Thanks very much for that. I knew RENX had made the test very user friendly but now the picture is in my mind. I believe the end user ease was one of the aspects that impressed Tempus.

You are obviously more knowledgeable in this field than myself and, I would guess, most of the posters here. Thanks for your input.

Thirty5KR, I can't find the nuts and bolts of the test. You seem to have details of it so it would be good to share maybe. What happens when the physician orders the test. Is blood taken, I can't imagine it doesn't, and if so what happens then? What is the process in other words?